Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

L-Carnitine and Reduced Mortality Rate

Research synthesisLow evidenceMixed effect size4 studies · 2 beneficial · 2 neutral · 0 harmful

Across 4 studies on L-carnitine and reduced mortality rate, 2 reported beneficial effects (one large, one large) and 2 found neutral effects (both small). The beneficial effects were observed in critically ill septic patients and individuals with acute aluminum phosphide poisoning, with doses ranging from 3 g/day in one trial. The median study duration was 186 days, but effects on mortality were typically measured at 28 days or 12 months.

  • Effective dose range: 3 g/day (only one study reported dose)
  • Studied populations: critically ill septic patients, individuals with acute aluminum phosphide poisoning

Caveats: Evidence base is small (only 4 studies) — conclusions should be considered preliminary. Many of the included studies did not reach statistical significance — effect may be smaller than the predominant direction suggests. Two meta-analyses showed neutral results with wide confidence intervals, while two smaller RCTs showed significant benefits; the discrepancy may reflect differences in populations or study power.

Generated Jul 12, 2026
Doses used in studies
  • g/day: 3 (median 3, IQR 33) 1 study
Time to effect
Median: 6.2 months · IQR 3.2 months9.2 months · Range 7 days12.2 months — Reported in 2 of 4 studies
4 of 4 papers
Back to top